North America Needle-free Drug Delivery Devices Market Size & Outlook

The needle-free drug delivery devices market in North America is expected to reach a projected revenue of US$ 11,806.5 million by 2030. A compound annual growth rate of 11.2% is expected of North America needle-free drug delivery devices market from 2025 to 2030.
Revenue, 2024 (US$M)
$6,285.2
Forecast, 2030 (US$M)
$11,806.5
CAGR, 2025 - 2030
11.2%
Report Coverage
North America

North America needle-free drug delivery devices market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

North America needle-free drug delivery devices market, 2018-2030 (US$M)

Related Markets

North America needle-free drug delivery devices market highlights

  • The North America needle-free drug delivery devices market generated a revenue of USD 6,285.2 million in 2024.
  • The market is expected to grow at a CAGR of 11.2% from 2025 to 2030.
  • In terms of segment, jet injectors was the largest revenue generating technology in 2024.
  • Transdermal patch technology is the most lucrative technology segment registering the fastest growth during the forecast period.
  • Country-wise, Canada is expected to register the highest CAGR from 2025 to 2030.

North America data book summary

Market revenue in 2024USD 6,285.2 million
Market revenue in 2030USD 11,806.5 million
Growth rate11.2% (CAGR from 2025 to 2030)
Largest segmentJet injectors
Fastest growing segmentTransdermal patch technology
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationJet injectors, Inhaler technology, Transdermal patch technology, Novel needle-free technologies
Key market players worldwide3M Co, PHARMAJET, Verdict Media Group, Endo Pharmaceuticals

Other key industry trends

  • In terms of revenue, North America region accounted for 42.8% of the global needle-free drug delivery devices market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 6,864.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Needle-Free Drug Delivery Devices Market Companies

Name Profile # Employees HQ Website

North America needle-free drug delivery devices market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to needle-free drug delivery devices market will help companies and investors design strategic landscapes.


Jet injectors was the largest segment with a revenue share of 31.48% in 2024. Horizon Databook has segmented the North America needle-free drug delivery devices market based on jet injectors, inhaler technology, transdermal patch technology, novel needle-free technologies covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to North America needle-free drug delivery devices market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America needle-free drug delivery devices market databook

  • Our clientele includes a mix of needle-free drug delivery devices market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America needle-free drug delivery devices market , including forecasts for subscribers. This continent databook contains high-level insights into North America needle-free drug delivery devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America needle-free drug delivery devices market size, by country, 2018-2030 (US$M)

North America Needle-Free Drug Delivery Devices Market Outlook Share, 2024 & 2030 (US$M)

North America needle-free drug delivery devices market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more